In addition to MNA+ NB, we also found markedly increased MYO1B expression in a range of other human cancers including cervical, colon, esophageal, head and neck, rectal, stomach, testicular, melanoma, thymoma, and diffuse large B cell lymphoma, as compared with their respective normal control tissues. Here, MYO1B is linked to thymoma.